AI for Pharma Market Access” Course Launches in 2025
The AI for Pharma Market Access Course is poised to become a transformative learning experience for ...
April 9 - June 6ISPOR 2025 – The Leading HEOR Conference
Advancing Health Economics and Outcomes Research Globally ISPOR 2025 is set to take place on May 18-...
May 13 - May 16London Biotechnology Show 2025
Accelerating Medical Biotechnology Globally The London Biotechnology Show 2025 is scheduled for June...
June 18 - June 19ISPOR Europe 2025
The Leading Global Conference for Health Economics and Outcomes Research ISPOR Europe 2025, the prem...
November 9 - November 12
Hospitals that enhance their nursing work environments and increase the number of Bachelor of Science-prepared nurses are witnessing remarkable improvements in patient outcomes, according to a recent comprehensive study.
Study...
Healthcare professionals across different specialties exhibit distinct approaches when addressing urinary incontinence in individuals living with dementia. A recent study highlights these variances, emphasizing the need for collaborative strategies...
Individuals with Inflammatory Bowel Disease (IBD) undergoing coronary interventions exhibit a significantly higher likelihood of experiencing major adverse cardiovascular events, according to recent nationwide research.
Study Overview
The nationwide cohort study...
Clinical Researches
New Trial Evaluates Dato-DXd Plus Durvalumab for Advanced Triple-Negative Breast Cancer
In a significant advancement for triple-negative breast cancer (TNBC) treatment, the ongoing TROPION-Breast05 phase III study is testing the combination of datopotamab deruxtecan (Dato-DXd) and durvalumab against the current...
Upcoming Meetings
Pharmacoeconomics
Latest NewsLatest
Strengthening Nursing Teams Reduces Mortality in Chronic Wound Cases
Hospitals that enhance their nursing work environments and increase the number of Bachelor of Science-prepared nurses are witnessing remarkable improvements in patient outcomes, according...
Child’s High Sirolimus Levels Linked to Rare CYP3A4 Variants, Study Finds
A recent clinical case reveals the limitations of current pharmacogenetic testing panels, highlighting a child's unexpected high sirolimus blood concentration. Despite following standard dosing...
China’s Long-Term Care Insurance Alters Elderly Living Patterns
China's introduction of Long-Term Care Insurance (LTCI) is reshaping how older adults choose to live, according to recent research. As the population ages, the...
ARB Recalls Trigger Significant Medication Switches Among Hypertension Patients
The 2018 recall of key angiotensin II receptor blockers (ARBs) due to carcinogenic contaminants has left a substantial impact on patients managing hypertension, heart...
Digital Tools Set to Revolutionize Type 2 Diabetes Coaching
Innovative digital solutions are poised to enhance the effectiveness of health coaching for individuals striving to achieve remission from type 2 diabetes. A recent...
Specialists Vary in Treating Incontinence in Dementia Patients
Healthcare professionals across different specialties exhibit distinct approaches when addressing urinary incontinence in individuals living with dementia. A recent study highlights these variances, emphasizing...
US Eyes 45 New Treatments for Rare Pediatric Diseases by 2033
Advancements in the pharmaceutical pipeline are set to significantly impact the lives of millions of Americans suffering from rare pediatric diseases. With over 30...
JAMA Set to Release Pivotal Study on April 29, 2025
The Journal of the American Medical Association (JAMA) is preparing to unveil a significant study on April 29, 2025. This forthcoming publication is anticipated...
Immunochemotherapy Boosts Survival Rates in Advanced Oral Cancer
New developments in cancer treatment have offered hope to patients with locally advanced oral squamous cell carcinoma (LA-OSCC), as a recent phase II trial...
Updated SPIRIT Guidelines Enhance Trial Protocol Transparency
Researchers have introduced the SPIRIT 2025 statement, a comprehensive update to the existing guidelines for designing randomized trial protocols. This initiative aims to standardize...
